1. Home
  2. RCI vs BIIB Comparison

RCI vs BIIB Comparison

Compare RCI & BIIB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rogers Communication Inc.

RCI

Rogers Communication Inc.

HOLD

Current Price

$37.58

Market Cap

21.1B

ML Signal

HOLD

Logo Biogen Inc.

BIIB

Biogen Inc.

HOLD

Current Price

$181.52

Market Cap

24.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RCI
BIIB
Founded
1960
1978
Country
Canada
United States
Employees
N/A
N/A
Industry
Cable & Other Pay Television Services
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
21.1B
24.2B
IPO Year
N/A
1991

Fundamental Metrics

Financial Performance
Metric
RCI
BIIB
Price
$37.58
$181.52
Analyst Decision
Hold
Buy
Analyst Count
2
23
Target Price
$34.50
$176.48
AVG Volume (30 Days)
894.8K
1.9M
Earning Date
10-23-2025
10-30-2025
Dividend Yield
3.81%
N/A
EPS Growth
341.45
N/A
EPS
8.96
10.97
Revenue
$15,091,643,989.00
$10,065,900,000.00
Revenue This Year
$7.45
$3.61
Revenue Next Year
$5.57
N/A
P/E Ratio
$4.18
$16.52
Revenue Growth
2.75
4.77
52 Week Low
$23.18
$110.04
52 Week High
$40.26
$185.17

Technical Indicators

Market Signals
Indicator
RCI
BIIB
Relative Strength Index (RSI) 44.04 72.92
Support Level $37.42 $174.53
Resistance Level $39.25 $182.94
Average True Range (ATR) 0.65 5.22
MACD -0.16 0.25
Stochastic Oscillator 8.47 83.54

Price Performance

Historical Comparison
RCI
BIIB

About RCI Rogers Communication Inc.

Rogers Communications is the largest wireless service provider in Canada with more than 11 million subscribers, equating to one-third of the total Canadian market. Rogers' wireless business accounts for more than half of total revenue and has been growing at a higher rate than other segments. The cable segment, which provides about 38% of total revenue after acquiring Shaw, offers home internet, television, and landline phone service to consumers and businesses. Remaining sales come from Rogers' media unit, which owns and operates various television and radio stations and the Toronto Blue Jays. Rogers' significant exposure to sports also includes ownership stakes in the Maple Leafs, Raptors, Toronto FC, and Argonauts.

About BIIB Biogen Inc.

Biogen is an established biopharmaceutical company focused on treatments for neurological diseases and rare diseases. Its declining multiple sclerosis franchise is its largest revenue generator and contributed 45% of total revenue in 2024. Biogen also generates significant revenue from its CD20 collaboration agreements with Roche (18% of total in 2024), which includes oncology drugs Rituxan and Gazyva and multiple sclerosis drug Ocrevus. Biogen's newer franchises include Spinraza (spinal muscular atrophy, with partner Ionis), Leqembi (Alzheimer's disease, collabroation revenue from its partner Eisai), Skyclarys (Friedreich's ataxia, Reata), Zurzuvae (postpartum depression, Sage), and Qalsody (amyotrophic lateral sclerosis, Ionis).

Share on Social Networks: